Literature DB >> 33728787

Functionalized High Mannose-Specific Lectins for the Discovery of Type I Mannosidase Inhibitors.

Suresh E Kurhade1, Jack D Weiner1, Fei Philip Gao2, Mark P Farrell1.   

Abstract

An engineered cyanovirin-N homologue that exhibits specificity for high mannose N-glycans has been constructed to aid type I α 1,2-mannosidase inhibitor discovery and development. Engineering the lectins C-terminus permitted facile functionalization with fluorophores via a sortase and click strategy. The resulting lectin constructs exhibit specificity for cells presenting high mannose N-glycans. Importantly, these lectin constructs can also be applied to specifically assess changes in cell surface glycosylation induced by type I mannosidase inhibitors. Testing the utility of these lectin constructs led to the discovery of type I mannosidase inhibitors with nanomolar potency. Cumulatively, these findings reveal the specificity and utility of the functionalized cyanovirin-N homologue constructs, and highlight their potential in analytical contexts that require high mannose-specific lectins.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  bioconjugation; lectin; mannosidase inhibitors; natural products; protein modifications

Mesh:

Substances:

Year:  2021        PMID: 33728787      PMCID: PMC8131250          DOI: 10.1002/anie.202101249

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   16.823


  51 in total

1.  MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer.

Authors:  Hai-Feng Wang; Jian-Hui Wu; Jun-Wei Gai; Shi-Qiang Yang; Qing-Tong Ma; Hong-Shun Ma; Qiang Feng
Journal:  Gene       Date:  2018-09-12       Impact factor: 3.688

2.  A practical synthesis of kifunensine analogues as inhibitors of endoplasmic reticulum alpha-mannosidase I.

Authors:  Kirk W Hering; Khanita Karaveg; Kelley W Moremen; William H Pearson
Journal:  J Org Chem       Date:  2005-11-25       Impact factor: 4.354

3.  Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: calorimetric and NMR characterization.

Authors:  Shilpa R Shenoy; Laura G Barrientos; Daniel M Ratner; Barry R O'Keefe; Peter H Seeberger; Angela M Gronenborn; Michael R Boyd
Journal:  Chem Biol       Date:  2002-10

4.  Structure and Glycan Binding of a New Cyanovirin-N Homolog.

Authors:  Elena Matei; Rohan Basu; William Furey; Jiong Shi; Conor Calnan; Christopher Aiken; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2016-07-07       Impact factor: 5.157

5.  A new immunomodulator, FR-900494: taxonomy, fermentation, isolation, and physico-chemical and biological characteristics.

Authors:  M Iwami; O Nakayama; H Terano; M Kohsaka; H Aoki; H Imanaka
Journal:  J Antibiot (Tokyo)       Date:  1987-05       Impact factor: 2.649

Review 6.  Intracellular functions of N-linked glycans.

Authors:  A Helenius; M Aebi
Journal:  Science       Date:  2001-03-23       Impact factor: 47.728

7.  Putative sperm fusion protein IZUMO and the role of N-glycosylation.

Authors:  Naokazu Inoue; Masahito Ikawa; Masaru Okabe
Journal:  Biochem Biophys Res Commun       Date:  2008-10-24       Impact factor: 3.575

8.  Synthesis of kifunensine thioanalogs and their inhibitory activities against HIV-RT and α-mannosidase.

Authors:  Hua Chen; Rui Li; Zhenying Liu; Sinan Wei; Hongzhi Zhang; Xiaoliu Li
Journal:  Carbohydr Res       Date:  2012-10-27       Impact factor: 2.104

9.  Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.

Authors:  Fabienne Hamester; Karen Legler; Beatrice Wichert; Nicole Kelle; Kathrin Eylmann; Maila Rossberg; Yi Ding; Sascha Kürti; Barbara Schmalfeldt; Karin Milde-Langosch; Leticia Oliveira-Ferrer
Journal:  Br J Cancer       Date:  2019-10-29       Impact factor: 7.640

Review 10.  Protein glycosylation in infectious disease pathobiology and treatment.

Authors:  David J Vigerust
Journal:  Cent Eur J Biol       Date:  2011-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.